I don't think you and I have ever discussed this before, but at one time I was the CEO of a biotech company. When I was a resident in surgery, I made a discovery in the area of radiotherapy. I found something that seemed to make radiotherapy work better for cancer. I had an interesting journey with that company. I call it Canada's least successful biotechnical company, yet I'm still convinced that our product was a working product, a product that would have been helpful.
Technology transfer, which is taking something from the eureka on the bench to the marketplace, is a challenging and cumbersome prospect. It cost us $50,000 to patent our project, and we had to do that before I could even utter a word about it in public. I was a resident, and that was my project for that year. I had to patent it before I had the opportunity to present it to my colleagues and pass my residency.